Urinary isoflavones are increased in adults, but decreased in children, consuming soy when on oral antibiotic therapy

Nutrition and Cancer

Volumn 60, Issue 5, 2008, Pages 627-635

  Franke, Adrian A ^a   Halm, Brunhild M ^a   Ashburn, Leslie A ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFDINIR; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; CREATININE; DAIDZEIN; DOXYCYCLINE; EQUOL; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; ISOFLAVONOID; MOXIFLOXACIN; O DESMETHYLANGOLENSIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRONCHITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG METABOLISM; EAR INFECTION; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOOD DRUG INTERACTION; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MALE; NORMAL HUMAN; PHARYNGITIS; SINUSITIS; SOYBEAN; STAPHYLOCOCCUS INFECTION; TONSILLITIS; TOOTH ABSCESS; URINALYSIS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENISTEIN; HUMANS; ISOFLAVONES; MALE; PHYTOESTROGENS; SOY FOODS; SOYBEANS;

EID: 51849134126     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802065310     Document Type: Article

References (50)

1. Halm B, Ashburn L, and Franke A: Isoflavones from soya foods are more bioavailable in children than adults. Br J Nutr 98, 998-1005, 2007.
2. Halm B, Franke A, Ashburn L, Hebshi S, and Wilkens L: Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer 60, 14-22, 2008.
3. Hoey L, Rowland IR, Lloyd AS, Clarke DB, and Wiseman H: Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91, 607-616, 2004.
4. Messina M, Persky V, Setchell KDR, and Barnes S: Soy intake and cancer risk: a review of in vitro and in vivo data. Nutr Cancer 21, 113-131, 1994.
5. Barnes S, Grubbs C, Setchell KDR, and Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. In: Mutagens and Carcinogens in the Diet, Pariza W, Aeschbacher U, Felton JS, and Sato S (eds.). New York: Wiley-Liss, 1990, pp. 239-254.
6. Lamartiniere CA, Moore J, Holland M, and Barnes S: Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Bio Med 208, 120-123, 1995.
7. Murrill WB, Brown NM, Zhang J-X, Manzolillo PA, Barnes S, et al.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457, 1996.
8. Pollard M and Luckert PH: Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 28, 41-45, 1997.
9. Zhang J-X, Hallmans G, Landstrom M, Bergh A, Damber JE, et al.: Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett 114, 313-314, 1997.
10. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, et al.: Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267, 886-891, 1995.
11. Shu XO, Jin F, Dai Q, Wen W, Potter JD, et al.: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483-488, 2001.
12. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, et al.: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496, 2002.
13. Umphress ST, Murphy SP, Franke AA, Custer LJ, and Blitz CL: Isoflavone content of foods with soy additives. J Food Comp Anal 18, 533-550, 2005.
14. Franke AA, Custer LJ, Cerna CM, and Narala K: Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 208, 18-26, 1995.
15. Adlercreutz H and Mazur W: Phyto-estrogens and Western diseases. Ann Med 29, 95-120, 1997.
16. Horn-Ross PL, Lee M, John EM, and Koo J: Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 11, 299-302, 2000.
17. Franke AA, Custer LJ, Wang W, and Shi SJ: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263-273, 1998.
18. Franke AA, Custer LJ, and Hundahl SA: Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 50, 141-154, 2004.
19. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, et al.: Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027-1035, 2003.
20. Zubik L and Meydani M: Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 77, 1459-1465, 2003.
21. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M, and Offord EA: Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132, 2587-2592, 2002.
22. Hollman PCH: Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol 42, 74-83, 2004.
23. Seow A, Shi C-Y, Franke AA, Hankin J, Lee H-P, et al.: Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7, 135-140, 1998.
24. Chen Z, Zheng W, Custer LJ, Dai Q, Shu X-O, et al.: Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoid in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33, 82-89, 1999.
25. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, et al.: Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11, 253-260, 2002.
26. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, et al.: Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition - Norfolk. Cancer Epidemiol Biomarkers Prev 13, 698-708, 2004.
27. Wu AH, Yu MC, Tseng CC, Twaddle NC, and Doerge DR: Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 25, 77-81, 2004.
28. Fanti P, Stephenson TJ, Kaariainen IM, Rezkalla B, Tsukamoto Y, et al.: Soy food intake and serum levels of soy isoflavones in Japanese, Thai and North American end-stage renal failure patients on chronic hemodialyis therapy. Nephrol Dial Transplant 18, 1862-1868, 2003.
29. Ritchie MR, Morton MS, Deighton N, Blake A, and Cummings JH: Plasma and urinary phyto-oestrogens as biomarkers of intake: validation by duplicate diet analysis. Br J Nutr 91, 447-457, 2004.
30. Franke AA, Halm BM, Custer LJ, Tatsumura Y, and Hebshi S: Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84, 406-413, 2006.
31. Atkinson C, Frankenfeld CL, and Lampe JW: Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230, 155-170, 2005.
32. Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, et al.: Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 13, 1156-1162, 2004.
33. Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, et al.: Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas 53, 315-324, 2006.
34. Setchell KDR, Borriello SP, Hulme P, Kirk DN, and Axelson M: Nonsteroidal estrogens of dietary origin: possible roles in hormone- dependent disease. Am J Clin Nutr 40, 569-578, 1984.
35. Franke AA and Custer LJ: High-performance liquid chromatography assay of isoflavonoids and coumestrol from human urine. J Chromatogr B 662, 47-60, 1994.
36. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, et al.: Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47, 977-986, 1999.
37. Blair RM, Appt SE, Franke AA, and Clarkson TB: Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133, 2262-2267, 2003.
38. Franke AA, Custer LJ, Wilkens LR, Le Marchand L, Nomura ANs, et al.: Liquid chromatographic analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B 777, 43-57, 2002.
39. Maskarinec G, Hebshi S, Custer L, and Franke A: The relation of soy intake and isoflavone levels in nipple aspirate fluid. European J Cancer Prev 17, 67-70, 2008.
40. Fomon SJ: Nutrition of Normal Infants. St. Louis, MO: Mosby, 1993.
41. Remer T, Neubert A, and Maser-Gluth C: Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75, 561-569, 2002.
42. Kesteloot H and Joossens JV: On the determinants of the creatinine clearance: a population study. J Hum Hypertens 10, 245-249, 1996.
43. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, et al.: Urinary creatinine concentrations in the U.S. population: implications for urinary biologicmonitoring measurements. Environ Health Perspect 113, 192-200, 2005.
44. Kampmann J, Siersbaek-Nielsen K, Kristensen M, and Hansen JM: Rapid evaluation of creatinine clearance. Acta Med Scand 196, 517-520, 1974.
45. Kardas P: Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 49, 897-903, 2002.
46. Ramalle-Gomara E, Bermejo-Ascorbe R, Alonso Marin R, Marino Alejo I, Saenz de Cabezon Bustinduy MI, et al.: [Compliance with antibiotic treatment in nonhospitalized children]. Aten Primaria 24, 364-367, 1999.
47. Arai Y, Uehara M, Kimira M, and Watanabe S: Effects of soybean isoflavones on bone mineral density and bone metabolism in women: correlation among isoflavone concentrations in biological fluids, sex-hormone binding globulin and bone biomarkers. Soy Protein Res, Japan 4, 135-141, 2001.
48. King R: Digestion, absorption, and metabolism of isoflavones. In: Phytoestrogens and Health, Gilani G and Anderson J (eds.). Urbana, IL: AOCS Press, 2002, pp. 209-234.
49. Franke AA, Halm BM, Custer LJ, Tatsumura Y, and Hebshi S: Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84, 406-413, 2006.
50. Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ, et al.: Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study. Nutr Cancer 52, 22-28, 2005.